13don MSN
Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, ...
Hosted on MSN8d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patientsA Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results